메뉴 건너뛰기




Volumn 85, Issue 2, 2007, Pages 176-177

FDG-PET scan and treatment planning for early stage Hodgkin lymphoma

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

EID: 36349000306     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.08.009     Document Type: Editorial
Times cited : (7)

References (19)
  • 1
    • 36349025232 scopus 로고    scopus 로고
    • Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?
    • Girinsky T., Ghalibafian M., Bonniaud G., et al. Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?. Radiother Oncol (2007)
    • (2007) Radiother Oncol
    • Girinsky, T.1    Ghalibafian, M.2    Bonniaud, G.3
  • 2
    • 33947496614 scopus 로고    scopus 로고
    • Revised response criteria for malignant lymphoma
    • Cheson B.D., Pfistner B., Juweid M.E., et al. Revised response criteria for malignant lymphoma. J Clin Oncol 25 (2007) 579-586
    • (2007) J Clin Oncol , vol.25 , pp. 579-586
    • Cheson, B.D.1    Pfistner, B.2    Juweid, M.E.3
  • 3
    • 21044443290 scopus 로고    scopus 로고
    • Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT)
    • Yahalom J. Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT). Eur J Haematol 75 (2005) 90-97
    • (2005) Eur J Haematol , vol.75 , pp. 90-97
    • Yahalom, J.1
  • 4
    • 4344699405 scopus 로고    scopus 로고
    • ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results
    • Bonadonna G., Bonfante V., Viviani S., Di Russo A., Villani F., and Valagussa P. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results. J Clin Oncol 22 (2004) 2835-2841
    • (2004) J Clin Oncol , vol.22 , pp. 2835-2841
    • Bonadonna, G.1    Bonfante, V.2    Viviani, S.3    Di Russo, A.4    Villani, F.5    Valagussa, P.6
  • 5
    • 0141939066 scopus 로고    scopus 로고
    • Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
    • Engert A., Schiller P., Josting A., et al. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21 (2003) 3601-3608
    • (2003) J Clin Oncol , vol.21 , pp. 3601-3608
    • Engert, A.1    Schiller, P.2    Josting, A.3
  • 6
    • 4243633257 scopus 로고    scopus 로고
    • MOPP/ABV hybrid and irradiation in unfavorable supradiaphragmatic clinical stages I-II Hodgkin's disease: comparison of three treatment modalities. Preliminary results of the EORTC-GELA H8-U randomized trial in 995 patients
    • Ferme C., Eghbali H., Hagenbeek A., et al. MOPP/ABV hybrid and irradiation in unfavorable supradiaphragmatic clinical stages I-II Hodgkin's disease: comparison of three treatment modalities. Preliminary results of the EORTC-GELA H8-U randomized trial in 995 patients. Blood 96 (2000) 576A
    • (2000) Blood , vol.96
    • Ferme, C.1    Eghbali, H.2    Hagenbeek, A.3
  • 7
    • 33746868428 scopus 로고    scopus 로고
    • Comparison of three radiation dose levels after EBVP regimen in favorable supradiaphragmatic clinical stages (CS) I-II Hodgkin's lymphoma (HL): preliminary results of the EORTC-GELA H9-F trial
    • Eghbali H., Brice P., Creemers G.-Y., et al. Comparison of three radiation dose levels after EBVP regimen in favorable supradiaphragmatic clinical stages (CS) I-II Hodgkin's lymphoma (HL): preliminary results of the EORTC-GELA H9-F trial. Blood 106 (2005) 240A
    • (2005) Blood , vol.106
    • Eghbali, H.1    Brice, P.2    Creemers, G.-Y.3
  • 8
    • 23044452477 scopus 로고    scopus 로고
    • Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
    • Meyer R.M., Gospodarowicz M.K., Connors J.M., et al. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol 23 (2005) 4634-4642
    • (2005) J Clin Oncol , vol.23 , pp. 4634-4642
    • Meyer, R.M.1    Gospodarowicz, M.K.2    Connors, J.M.3
  • 9
    • 0037106383 scopus 로고    scopus 로고
    • Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy
    • Nachman J.B., Sposto R., Herzog P., et al. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 20 (2002) 3765-3771
    • (2002) J Clin Oncol , vol.20 , pp. 3765-3771
    • Nachman, J.B.1    Sposto, R.2    Herzog, P.3
  • 10
    • 33845354279 scopus 로고    scopus 로고
    • Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials
    • Franklin J., Pluetschow A., Paus M., et al. Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol 17 (2006) 1749-1760
    • (2006) Ann Oncol , vol.17 , pp. 1749-1760
    • Franklin, J.1    Pluetschow, A.2    Paus, M.3
  • 11
    • 36348941080 scopus 로고    scopus 로고
    • Very long-term follow-up of the Danish National Hodgkin Study Group's randomized trial of radiotherapy (RT) alone vs. combined modality treatment (CMT) for early stage Hodgkin lymphoma, with special reference to second tumours and overall survival
    • Specht L. Very long-term follow-up of the Danish National Hodgkin Study Group's randomized trial of radiotherapy (RT) alone vs. combined modality treatment (CMT) for early stage Hodgkin lymphoma, with special reference to second tumours and overall survival. Blood 102 (2003) 637A
    • (2003) Blood , vol.102
    • Specht, L.1
  • 12
  • 13
    • 33746346422 scopus 로고    scopus 로고
    • Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines
    • Girinsky T., van der Maazen R., Specht L., et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 79 (2006) 270-277
    • (2006) Radiother Oncol , vol.79 , pp. 270-277
    • Girinsky, T.1    van der Maazen, R.2    Specht, L.3
  • 14
    • 34250698039 scopus 로고    scopus 로고
    • 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas
    • Specht L. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. Semin Radiat Oncol 17 (2007) 190-197
    • (2007) Semin Radiat Oncol , vol.17 , pp. 190-197
    • Specht, L.1
  • 15
    • 33846965941 scopus 로고    scopus 로고
    • Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma
    • Hutchings M., Loft A., Hansen M., Berthelsen A.K., and Specht L. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Eur J Haematol 78 (2007) 206-212
    • (2007) Eur J Haematol , vol.78 , pp. 206-212
    • Hutchings, M.1    Loft, A.2    Hansen, M.3    Berthelsen, A.K.4    Specht, L.5
  • 16
    • 33645963756 scopus 로고    scopus 로고
    • Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma
    • Hutchings M., Loft A., Hansen M., et al. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 91 (2006) 482-489
    • (2006) Haematologica , vol.91 , pp. 482-489
    • Hutchings, M.1    Loft, A.2    Hansen, M.3
  • 17
    • 0035074636 scopus 로고    scopus 로고
    • Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease
    • Jerusalem G., Beguin Y., Fassotte M.F., et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica 86 (2001) 266-273
    • (2001) Haematologica , vol.86 , pp. 266-273
    • Jerusalem, G.1    Beguin, Y.2    Fassotte, M.F.3
  • 18
    • 0036405370 scopus 로고    scopus 로고
    • Positron emission tomography for the staging of Hodgkin's lymphoma - increasing the body of evidence in favor of the method
    • Menzel C., Dobert N., Mitrou P., et al. Positron emission tomography for the staging of Hodgkin's lymphoma - increasing the body of evidence in favor of the method. Acta Oncol 41 (2002) 430-436
    • (2002) Acta Oncol , vol.41 , pp. 430-436
    • Menzel, C.1    Dobert, N.2    Mitrou, P.3
  • 19
    • 0036124658 scopus 로고    scopus 로고
    • Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma
    • Wirth A., Seymour J.F., Hicks R.J., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. Am J Med 112 (2002) 262-268
    • (2002) Am J Med , vol.112 , pp. 262-268
    • Wirth, A.1    Seymour, J.F.2    Hicks, R.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.